We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
+$101M
Cap. Flow
+$158M
Cap. Flow %
1.07%
Top 10 Hldgs %
22.11%
Holding
946
New
64
Increased
332
Reduced
304
Closed
69

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$57.5M
2
AZN icon
AstraZeneca
AZN
+$44.9M
3
ADSK icon
Autodesk
ADSK
+$43.5M
4
MELI icon
Mercado Libre
MELI
+$40.7M
5
AMGN icon
Amgen
AMGN
+$33.6M

Sector Composition

Rank Sector Weight
1 Healthcare 32.09%
2 Technology 24.53%
3 Financials 9.08%
4 Communication Services 8.24%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNQ icon
726
Canadian Natural Resources
CNQ
$96.9B
$720K ﹤0.01%
40,240
+942
+2% +$15.5K
ELAN icon
727
Elanco Animal Health
ELAN
$13.2B
$717K ﹤0.01%
22,491
DISCK
728
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$714K ﹤0.01%
29,404
LW icon
729
Lamb Weston
LW
$7.42B
$703K ﹤0.01%
11,455
CMA
730
DELISTED
Comerica
CMA
$701K ﹤0.01%
8,711
RCI icon
731
Rogers Communications
RCI
$18.8B
$700K ﹤0.01%
14,997
-31,327
-68% -$1.58M
MGA icon
732
Magna International
MGA
$18.8B
$683K ﹤0.01%
9,083
-4,887
-35% -$402K
LSXMK
733
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$677K ﹤0.01%
18,406
-3,040
-14% -$112K
APO icon
734
Apollo Global Management
APO
$69B
$676K ﹤0.01%
10,975
-1,275
-10% -$76.6K
GIB icon
735
CGI
GIB
$15.6B
$675K ﹤0.01%
7,952
-25,927
-77% -$2.33M
FNV icon
736
Franco-Nevada
FNV
$41.3B
$667K ﹤0.01%
5,132
+87
+2% +$12.7K
TAP icon
737
Molson Coors Class B
TAP
$8.02B
$656K ﹤0.01%
14,134
DISH
738
DELISTED
DISH Network Corp.
DISH
$656K ﹤0.01%
15,088
+2,767
+22% +$118K
SOXX icon
739
iShares Semiconductor ETF
SOXX
$38.4B
$655K ﹤0.01%
4,410
CF icon
740
CF Industries
CF
$19.6B
$654K ﹤0.01%
11,720
+116
+1% +$5.57K
CBOE icon
741
Cboe Global Markets
CBOE
$32.2B
$641K ﹤0.01%
5,174
-457
-8% -$55.8K
CSL icon
742
Carlisle Companies
CSL
$13.5B
$641K ﹤0.01%
+3,224
New +$651K
RUN icon
743
Sunrun
RUN
$2.26B
$641K ﹤0.01%
14,567
+2,650
+22% +$126K
IRM icon
744
Iron Mountain
IRM
$35.9B
$637K ﹤0.01%
14,653
-14,596
-50% -$657K
TXG icon
745
10x Genomics
TXG
$5.88B
$631K ﹤0.01%
4,334
+658
+18% +$113K
ELS icon
746
Equity Lifestyle Properties
ELS
$13.1B
$624K ﹤0.01%
7,991
-3,082
-28% -$253K
YUMC icon
747
Yum China
YUMC
$15.7B
$616K ﹤0.01%
10,600
-55,000
-84% -$3.38M
SU icon
748
Suncor Energy
SU
$77.7B
$605K ﹤0.01%
29,199
-3,118
-10% -$62.3K
WPM icon
749
Wheaton Precious Metals
WPM
$49.7B
$592K ﹤0.01%
15,748
-1,242
-7% -$54.2K
ACGL icon
750
Arch Capital
ACGL
$36.5B
$591K ﹤0.01%
15,491
-7,131
-32% -$282K

Similar funds

Candriam SCA's Q3 2021 Portfolio in Review

As of Q3 2021, Candriam SCA held 946 positions worth $14.7B, up 0.69% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA's Q3 2021 filing shows 64 new, 332 increased, 304 reduced and 69 closed positions. Its largest new stake was FIVE9: 86,075 shares worth $13.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2021 buy was FIVE9: 86,075 shares worth $13.7M.
  • Candriam SCA added most to Johnson & Johnson in Q3 2021, an estimated $57.5M increase.
  • Candriam SCA's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $88M.
  • Candriam SCA fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $92.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.7B portfolio in Q3 2021.
  • Candriam SCA opened 64 new positions and closed 69 in Q3 2021.
  • Candriam SCA's portfolio value rose 0.69% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.